ReValve Solutions announced this week that it completed the first human use of its transcatheter mitral valve replacement (TMVR) system.
Bainbridge Island, Washington-based ReValve Solutions said in a news release that the first procedure with its Palmetto TMVR system was performed at the Italian Hospital in Asuncion, Paraguay, by Dr. Charles Davison (medical director, Bluhm Cardiovascular Institute) and Dr. Edris Aman, (assistant clinical professor of cardiovascular medicine at the University of California, Davis Medicine Center, specialized in multimodality imaging). The successfully treated patient suffered from severe mitral valve regurgitation and heart failure.